docetaxel anhydrous has been researched along with tigapotide in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (tigapotide) | Trials (tigapotide) | Recent Studies (post-2010) (tigapotide) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 10 | 1 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kostopoulos, A; Koutsilieris, M; Papageorgiou, E; Sivolapenko, G | 1 |
1 other study(ies) available for docetaxel anhydrous and tigapotide
| Article | Year |
|---|---|
PCK3145 inhibits proliferation and induces apoptosis in breast and colon cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Proliferation; Colonic Neoplasms; Docetaxel; Female; HT29 Cells; Humans; MAP Kinase Signaling System; MCF-7 Cells; Organoplatinum Compounds; Oxaliplatin; Peptide Fragments; Prostatic Secretory Proteins; Receptors, Laminin; Taxoids | 2015 |